News
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network: Revenue up 21.4% in the first quarter of 2025. The integrations of Spital Zofingen and CentroMedico are bearing fruit.
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network: Revenue up 21.4% in the first quarter of 2025. The integrations of Spital Zofingen and CentroMedico are bearing fruit.
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network becomes a partner of Mayo Clinic Care Network
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network becomes a partner of Mayo Clinic Care Network
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland's positive momentum continues in the first quarter of 2025, driven by the operational excellence of its flagship establishments
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland's positive momentum continues in the first quarter of 2025, driven by the operational excellence of its flagship establishments
These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?
President Donald Trump's macroeconomic policies are taking center stage on Wall Street. The 47th U.S. president has decided to implement aggressive tariffs on imported goods from most countries
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
Just like the rest of the stock market, pharmaceutical stocks are in a funk approaching the midweek mark, and it's looking like things might be about to get even worse for this particular pocket of
AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2024
AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2024
AEVIS VICTORIA SA - The hotel branch of AEVIS VICTORIA recorded strong growth in 2024, driven by the quality of its assets and the strength of its integrated model.
AEVIS VICTORIA SA - The hotel branch of AEVIS VICTORIA recorded strong growth in 2024, driven by the quality of its assets and the strength of its integrated model.
AEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025
AEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025
AEVIS VICTORIA SA - Swiss Medical Network publishes 2024 results and confirms the strength of its integrated care model
AEVIS VICTORIA SA - Swiss Medical Network publishes 2024 results and confirms the strength of its integrated care model
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for GLP-1 weight-loss drugs. Current runners-up Viking Therapeutics (NASDAQ:
AEVIS VICTORIA SA – Strong growth in 2024 revenue and improved profitability
AEVIS VICTORIA SA – Strong growth in 2024 revenue and improved profitability
2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond
If there were an official hierarchy of qualities that dividend seekers should consider before investing in a stock, a company's underlying business would almost certainly come ahead of its yield
Novartis Ag (NVS) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Novartis Ag (NYSE: NVS)Q4 2024 Earnings CallJan 31, 2025, 8:00 a.m. ET
Operator
Source Fool.com
Sonova HY 2025/26 Results: Strong sales and earnings growth in local currencies, outperforming the market
Sonova HY 2025/26 Results: Strong sales and earnings growth in local currencies, outperforming the market
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-News: BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery
EQS-News: BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery
Lonza Delivers a Strong Q3 2025 and Confirms Full-Year 2025 Outlook for its CDMO and CHI Businesses
Lonza Delivers a Strong Q3 2025 and Confirms Full-Year 2025 Outlook for its CDMO and CHI Businesses
Sonova expands AI leadership with innovations debuting at EUHA 2025
Sonova expands AI leadership with innovations debuting at
EUHA 2025
Lonza Nominates Claudia Süssmuth-Dyckerhoff as Board Member
Lonza Nominates Claudia Süssmuth-Dyckerhoff as Board Member
EQS-News: BB Biotech to be included in the SPI ESG Index
EQS-News: BB Biotech to be included in the SPI ESG Index
Eric Bernard takes over as Sonova CEO effective September 15, 2025
Eric Bernard takes over as Sonova CEO effective September 15, 2025
Lonza Appoints Jason Berndt as Head of Group Operations, and Maria Soler Nunez as Chief Quality Officer
Lonza Appoints Jason Berndt as Head of Group Operations, and Maria Soler Nunez as Chief Quality Officer
Sonova expands Infinio range and enters new market segment with Phonak’s smallest and first rechargeable in-the-ear hearing aid
Sonova expands Infinio range and enters new market segment with Phonak’s smallest and first rechargeable in-the-ear hearing aid